On Nov. 30, 2017, Scythian Biosciences Corp. (TSXV: SCYB) (Frankfurt: 9SB) (OTC Pink: SCCYF) announced that it had entered into a share purchase agreement to sell its wholly-owned subsidiary Go Green B.C. Medicinal Marijuana Ltd. to 1065703 B.C. Ltd.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination. Divesting of Go Green is not anticipated to have any material impact on Scythian’s operations.

Gowling WLG advised Scythian in this transaction with a team that included Peter Simeon and Susana Fonseca.